Carpachromene Ameliorates Insulin Resistance in HepG2 Cells via Modulating IR/IRS1/PI3k/Akt/GSK3/FoxO1 Pathway

Abstract

Insulin resistance contributes to several disorders including type 2 diabetes and cardiovascular diseases. Carpachromene is a natural active compound that inhibits α-glucosidase enzyme. The aim of the present study is to investigate the potential activity of carpachromene on glucose consumption, metabolism and insulin signalling in a HepG2 cells insulin resistant model. A HepG2 insulin resistant cell model (HepG2/IRM) was established. Cell viability assay of HepG2/IRM cells was performed after carpachromene/metformin treatment. Glucose concentration and glycogen content were determined. Western blot analysis of insulin receptor, IRS1, IRS2, PI3k, Akt, GSK3, FoxO1 proteins after carpachromene treatment was performed. Phosphoenolpyruvate carboxykinase (PEPCK) and hexokinase (HK) enzymes activity was also estimated. Viability of HepG2/IRM cells was over 90% after carpachromene treatment at concentrations 6.3, 10, and 20 µg/mL. Treatment of HepG2/IRM cells with carpachromene decreased glucose concentration in a concentration- and time-dependant manner. In addition, carpachromene increased glycogen content of HepG2/IRM cells. Moreover, carpachromene treatment of HepG2/IRM cells significantly increased the expression of phosphorylated/total ratios of IR, IRS1, PI3K, Akt, GSK3, and FoxO1 proteins. Furthermore, PEPCK enzyme activity was significantly decreased, and HK enzyme activity was significantly increased after carpachromene treatment. The present study examined, for the first time, the potential antidiabetic activity of carpachromene on a biochemical and molecular basis. It increased the expression ratio of insulin receptor and IRS1 which further phosphorylated/activated PI3K/Akt pathway and phosphorylated/inhibited GSK3 and FoxO1 proteins. Our findings revealed that carpachromene showed central molecular regulation of glucose metabolism and insulin signalling via IR/IRS1/ PI3K/Akt/GSK3/FoxO1 pathway.

Vincamine Modulates the Effect of Pantoprazole in Renal Ischemia/Reperfusion Injury by Attenuating MAPK and Apoptosis Signaling Pathways

“…The current focus on herbal products inspires scientists to investigate natural agents in many disorders [36][37][38][39]. Many studies have shown that natural components can play an essential role in preventing human diseases [40][41][42][43]. Among them, vincamine has been reported to shield human corneal epithelial cells (HCECs) from lipopolysaccharides (LPS)induced injuries.…”

A New EGFR Inhibitor from Ficus benghalensis Exerted Potential Anti-Inflammatory Activity via Akt/PI3K Pathway Inhibition

“…To further explain the mechanism of action of this new FAG, we investigated the expression of the EGFR protein before and after treatment on LPS- stimulated RAW 264.7 cells. EGFR has been studied extensively for developing anticancer agents [ 22 , 37 , 38 , 39 , 40 ]. Recently, several studies indicated that EGFR has a pathological role in non-neoplastic diseases.…”

“…However, NSAIDs applications are limited by some side effects such as bronchospasm, thrombosis, gastrointestinal bleeding, and renal failure [ 17 ]. Accordingly, extensive studies are underway to identify and develop natural products that can be used as antioxidant and anti-inflammatory agents [ 18 , 19 , 20 , 21 , 22 ].…”

Cytokinins: Wide-Spread Signaling Hormones from Plants to Humans with High Medical Potential

“…It is important to mention that more than 60% of current anticancer drugs come from natural sources [ 7 , 8 , 9 , 10 ]. In other pathophysiological conditions, such as cardiovascular diseases, diabetes mellitus, and multiple sclerosis, natural products have contributed clearly to the therapeutic protocols [ 11 , 12 , 13 , 14 ]. Some of the recently highlighted natural products are cytokinins (CKs), which have different pharmacological and medicinal actions.…”